Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...
Reexamination Certificate
2007-10-23
2007-10-23
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
C424S280100, C424S277100, C424S573000, C424S185100, C514S002600, C530S300000
Reexamination Certificate
active
10113800
ABSTRACT:
An isolated peptide or polypeptide containing the sequence VSIGLSFPMLP (SEQ ID NO:1), found in the secreted form of human MUC1, that enhances an immune response when administered to a mammal, compositions containing the peptide, host cells producing the peptide and methods of use. The peptide or polypeptide may be conjugated to a carrier protein and administered as part of a vaccine or immunogenic composition for prevention or treatment of a disease or disorder.
REFERENCES:
patent: 5861381 (1999-01-01), Chambon et al.
patent: WO 92/07000 (1992-04-01), None
Smorodinsky et al. Biochem. Biophys. Res. Commun. 228: 115-121, 1996.
Kumar et al. J. Immunol. 148: 1499-1505, 1992.
Bennett et al. Cancer Res. 43: 4183-4190, 1983.
Dorsey, Jr. Mantley
Herbert Lynn M.
Hnatyszyn H. James
Kraus Günter
Lopez Diana M.
Devi S.
Hobbs Ann S.
University of Miami
Venable LLP
LandOfFree
Mucin peptide with immunoenhancing properties does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mucin peptide with immunoenhancing properties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucin peptide with immunoenhancing properties will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853905